FDA Peptide Update: Category 2 Removals Explained FDA Poised to Ease Restrictions on Injectable Peptides Af Peptides: Legal and Regulatory Risks 503A Compounding Pharmacies Must Understand The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to Reconsider Ban on 7 Peptides in July After Pressure from Pharma Lobbying BigGo Finance Discover the shift in how certain peptides can now be legally prescribed and compounded by pharmacies. This change, influenced by Secretary Robert Kennedy's actions within the Department of Health and Human Services,